Table 3.
Control | Probucol | LXS | HXS | |
MIT (mm) | 0.89 ± 0.40 | 0.54 ± 0.15 | 0.48 ± 0.08 | 0.34 ± 0.05* |
LA (mm2) | 0.90 ± 1.18 | 1.35 ± 0.83 | 1.88 ± 0.91 | 2.01 ± 0.88 ▲ |
IELa (mm2) | 2.20 ± 0.65 | 2.16 ± 0.64 | 2.62 ± 1.03 | 2.52 ± 0.76 |
EELa (mm2) | 3.22 ± 0.63 | 3.34 ± 0.62 | 3.68 ± 1.18 | 3.40 ± 0.64 |
MA (mm2) | 1.02 ± 0.11 | 1.18 ± 0.43 | 1.06 ± 0.47 | 0.88 ± 0.30 |
IA (mm2) | 1.30 ± 0.68 | 0.81 ± 0.68 | 0.74 ± 0.14 | 0.51 ± 0.27 |
RL (%) | 34.00 ± 37.00 | 62.00 ± 24.00 ▲ | 70.00 ± 7.00 ▲▲ | 77.00 ± 14.00 |
PI | 0.43 ± 0.23 | 0.24 ± 0.18 ▲ | 0.21 ± 0.04 ▲▲ | 0.16 ± 0.09 ▲▲ |
Values are mean ± SD. *P < 0.05, significance vs. control: comparison of group means after ANOVA; ▲ P < 0.05, ▲▲ P < 0.01, significance vs. control: comparison of group means after ANOVA taking injury score as covariance.